ZEB1 and ovarian carcinoma: Current studies have shown that miR-34 could inhibit melanoma by targeting ZEB1,34 and miRNA-199b-3p could inhibit ovarian cancer by targeting ZEB1,35 suggesting that ZEB1 can be regulated by miRNA to play a key role in cancer.